免疫检查点抑制剂诱导的心肌瘤炎
Mohamed Alrayyashi1, Mohammed Uddin2, Mustafa Bdiwi1
1Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA.
BMJ case reports
|March 21, 2024
概括
免疫检查点抑制剂可以引起罕见但严重的心脏炎症,特别是心肌炎和心周炎. 早期诊断和治疗对于患者的生存至关重要.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 转移性直肠腺癌是一种复杂的恶性瘤.
- 免疫检查点抑制剂 (ICI),如 pembrolizumab,用于癌症治疗.
- ICI治疗很少会导致影响各种器官的免疫相关不良事件.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Heart Failure Drugs: Inotropic Agents
578
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
578


